Melinda J Carrington1, Garry L Jennings2, Mark Harris3, Mark Nelson4, Markus Schlaich5, Nigel P Stocks6, Louise M Burrell7, John Amerena8, Ferdinandus J de Looze9, Carla H Swemmer10, Nicol P Kurstjens10, Simon Stewart11. 1. Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia Baker IDI Heart and Diabetes Institute, Melbourne, Australia melinda.carrington@acu.edu.au. 2. Baker IDI Heart and Diabetes Institute, Melbourne, Australia. 3. Centre for Primary Health Care and Equity, University of New South Wales, Sydney, Australia. 4. Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia. 5. School of Medicine and Pharmacology, Royal Perth Hospital Unit, The University of Western Australia, Australia. 6. Discipline of General Practice, University of Adelaide, Australia. 7. Departments of Medicine and Cardiology, The University of Melbourne, Austin Health, Australia. 8. Geelong Cardiology Research Department, Deakin University, Australia. 9. School of Medicine, University of Queensland, Brisbane, Australia. 10. Novartis Pharmaceuticals Australia Ltd, Sydney, Australia. 11. Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia Baker IDI Heart and Diabetes Institute, Melbourne, Australia.